Nuevas guías de la Academia Americana de Pediatría | 21 JUN 23

Evaluación y manejo de lactantes febriles

Revisión de las nuevas guías de la Academia Americana de Pediatría sobre la evaluación y el manejo de lactantes febriles
Autor/a: Rianna Colette Leazer  Pediatr Rev. 2023 Mar 1; 44(3):127-138
INDICE:  1. Texto principal | 2. Referencia bibliográfica
Referencia bibliográfica

1. Pantell RH, Roberts KB, Adams WG et al; Subcommittee on Febrile Infants. Evaluation and Management of Well-appearing Febrile Infants 8 to 60 Days Old. Pediatrics. 2021;148(2): e202105228

2. Hammond K. The child with a fever. GP. 1954;10(5):44–48 Google Scholar PubMed

3. Baker CJ. Group B streptococcal infections in neonates. Pediatr Rev. 1979;1(1):5–15

4. Roberts KB, Pantell RH. Development of the new AAP febrile infant clinical practice guideline. Hosp Pediatr. 2021;11(9):1028–1032 d

5. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics. 2001;108(2):311–316

6. Dagan R, Powell KR, Hall CB, Menegus MA. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr. 1985; 107(6):855–860

7. Bonadio WA, Hagen E, Rucka J, Shallow K, Stommel P, Smith D. Efficacy of a protocol to distinguish risk of serious bacterial infection in the outpatient evaluation of febrile Young infants. Clin Pediatr (Phila). 1993; 32(7):401–404

8. Baskin MN, Fleisher GR, O’Rourke EJ. Identifying febrile infants at risk for a serious bacterial infection. J Pediatr. 1993; 123(3):489–490

9. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med. 1993; 329(20):1437–1441

10. Biondi EA, Mischler M, Jerardi KE et al; Pediatric Research in Inpatient Settings (PRIS) Network. Blood culture time to positivity in febrile infants with bacteremia. JAMA Pediatr. 2014; 168(9):844–849

11. Banerjee R, Teng CB, Cunningham SA et al. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis. 2015; 61(7):1071–1080

12. Leber AL, Everhart K, Balada-Llasat JM et al. Multicenter evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016; 54(9):2251–2261

13. Greenhow TL, Hung YY, Herz AM, Losada E, Pantell RH. The changing epidemiology of serious bacterial infections in young infants. Pediatr Infect Dis J. 2014; 33(6):595–599

14. Biondi E, Evans R, Mischler M et al. Epidemiology of bacteremia in febrile infants in the United States. Pediatrics. 2013; 132(6):990–996

15. Biondi EA, Mc Culloh R, Staggs VS et al; American Academy of Pediatrics’ REVISE Collaborative. Reducing Variability in the Infant Sepsis Evaluation (REVISE): a national quality initiative. Pediatrics. 2019; 144(3): e20182201

16. Leazer R, Perkins AM, Shomaker K, Fine B. A meta-analysis of the rates of Listeria monocytogenes and Enterococcus in febrile infants. Hosp Pediatr. 2016; 6(4):187–195 17. De Angelis C, Joffe A, Wilson M, Willis E. Iatrogenic risks and financial costs of hospitalizing febrile infants. Am J Dis Child. 1983; 137(12):1146–1149

18. Paxton RD, Byington CL. An examination of the unintended consequences of the rule-out sepsis evaluation: a parental perspective. Clin Pediatr (Phila). 2001;40(2):71–77

19. Pantell RH, Newman TB, Bernzweig J et al. Management and outcomes of care of fever in early infancy. JAMA. 2004; 291(10):1203–1212

20. Frosch DL, Kaplan RM. Shared decision making in clinical medicine: past research and future directions. Am J Prev Med. 1999; 17(4):285–294

21. Aronson PL, Shabanova V, Shapiro ED et al; Febrile Young Infant Research Collaborative. A prediction model to identify febrile infants <60 days at low risk of invasive bacterial infection. Pediatrics. 2019; 144(1): e20183604

22. Mahajan P, Browne LR, Levine DA et al; Febrile Infant Working Group of the Pediatric Emergency Care Applied Research Network (PECARN). Risk of bacterial coinfections in febrile infants 60 days old and younger with documented viral infections. J Pediatr. 2018; 203:86–91. e2

23. Nguyen THP, Young BR, Poggel LE, Alabaster A, Greenhow TL. Roseville protocol for the management of febrile infants 7–60 days. Hosp Pediatr. 2020;11(1):52–60

24. Michelson KA, Neuman MI, Pruitt CM et al; Febrile Young Infant Research Collaborative. Height of fever and invasive bacterial infection. Arch Dis Child. 2021;106(6):594– 596

25. Kuppermann N, Dayan PS, Levine DA et al; Febrile Infant Working Group of the Pediatric Emergency Care Applied Research Network (PECARN). A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections. JAMA Pediatr. 2019; 173(4):342–351

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024